SabineKaram United StatesUniversity of Minnesota

SabineKaram
Associate professor of medicine at the University of Minnesota, USA and adjunct faculty at the American University of Beirut, Lebanon. Chair of the Young Nephrologists Committee of the Internal Society of Nephrology (ISN) and a member of the 2021 cohort of the Emerging Leaders Program of the ISN.Clinical and research interests include Global Kidney Health, Onco-Nephrology, Hypertension and Peritoneal dialysis.
Institution

Day 1 - Sunday April 14, 2024

Time Session
9 a.m.
10:30 a.m.
YN
JavierNeyra Chairperson jneyra@uabmc.eduUnited StatesUniversity of Alabama at Birmingham
SabineKaram Chairperson United StatesUniversity of Minnesota
  • CELLULAR PRION PROTEIN ATTENUATES RENAL FIBROSIS BY INTERACTING WITH TSPAN7 TO INDUCE FORMATION OF MIGRASOME. YN Best Abstract Winner - Basic Science
    WeizeChen Free Communication 20111210015@fudan.edu.cnChina
  • Assessing Baseline Cardiovascular Disease for Kids Initiating Kidney Replacement Therapy: ABCD4Kids study. YN Best Abstract Winners - Clinical Science
    PriyankaKhandelwal Free Communication drpriyanka8588@gmail.comIndia
  • Blood Purification in Low Resource Settings: What is the Evidence and How Can It Be Implemented?
    ThiagoDe Azevedo Reis Speaker thiagoreisnefro@gmail.comBrazilHospital Sírio-Libanês, São Paulo, Brazil & Fenix
  • Novel Concepts of AKI Sub-phenotyping and Augmented Clinical Decision Support for AKI Care
    VicenteCampolo Girard Speaker vmcampolo@icloud.comArgentinaUniversidad de Buenos Aires
  • Roundtable: Implementation, Challenges and Pipeline of Development and Sustainability of Critical Care Nephrology Programs in Latin America
    Dario XavierJimenez Acosta Speaker dxjimenezmd@gmail.comEcuadorUniversity Quito-Ecuador, Enrique Garcés Hospital
    Dr. Lilia Rizo Topete Speaker lilia.rizo@udem.eduMexicoHospital Universitario "José Eleuterio Gonzá
    KrissiaWallbach-Massai Speaker krissia.wallbach@gmail.comBrazil
    Mariano RafaelFarias Speaker marianofarias20@hotmail.comArgentinaDr.
Hall C3

Day 2 - Monday April 15, 2024

Time Session
4:30 p.m.
5:30 p.m.
CHAL05
CarolineLamarche Chairperson caroline.lamarche.1@umontreal.caCanadaUniversité de Montréal
Gustavo CristianGreloni Chairperson gustavo.greloni@hospitalitaliano.org.arArgentina
  • MGRS: Should All Forms Need Clonal Therapy?
    FrankBridoux Speaker f.bridoux@chu-poitiers.frFranceDepartment of Nephrology and French Reference Center for AL amyloidosis and MGRS, University Hospital, Poitiers, France
  • Renal Amyloidosis: What Is New?
    Veronica Torres CostaSilva Speaker veronica.torres@hc.fm.usp.brBrazilSão Paulo State Cancer Institute - University of São Paulo
  • Can We Perform a Transplant in Patients with Myeloma and Amyloidosis?
    SabineKaram Speaker United StatesUniversity of Minnesota
  • Q and A
Hall A